X

Stay Connected

Sign Up for Updates

network1.png

PPA strives to improve patient health, advance medical innovation and fuel economic growth.

LEARN MORE
network1.png

The PhRMA Foundation supports the research and career endeavors of scientists in drug discovery and development.

LEARN MORE
network1.png

Access Better Coverage educates consumers about the ABCs of health coverage and access to medicines.

LEARN MORE
network1.png

We Work For Health aims to increase awareness by uniting workers throughout the industry.

LEARN MORE
network1.png

Patent protection should always be considered by an inventor during the initial stages of their invention.

LEARN MORE
logo_white_MyOldMeds-New-1.png

Working to spread awareness and education about the importance of secure drug disposal.

LEARN MORE
LTAC_NEW21.png

Many Americans are struggling to afford their medicines and have important questions about their medicine costs. Let's Talk About Cost addresses these questions.

LEARN MORE
logo_white_LTAM.png

There are a lot of conversations in Washington about how to change Medicare Part D, but they aren't always focused on what seniors care about most: affordability and predictability.

LEARN MORE
 
We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Innovative contracts continue to gain traction and improve quality of care

By Katie Koziara  |    May 2, 2022
Innovative contracts can help bring more value to patients and the health care system. These types of payment arrangements can include:   Read More

Study finds nearly half of payers believe innovative contracts can lead to lower patient out-of-pocket costs

By Katie Koziara  |    May 17, 2021
According to a recent survey by Verpora that will be presented this week at ISPOR, nearly half of U.S. payers surveyed expressed a belief that wider implementation of innovative contracts could lead...   Read More

PhRMA submits comments to CMS on Medicaid proposed rule

By Nicole Longo  |    July 21, 2020
In response to the Centers for Medicare and Medicaid Services’ (CMS) proposed rule regarding changes to Medicaid, PhRMA provided feedback on how the changes included would have widespread impacts on...   Read More

Clarity around anti-kickback statute needed to promote innovative payment arrangements

By Michelle Drozd  |    January 10, 2018
You may have recently read about how biopharmaceutical companies and insurers are working together to implement new approaches to paying for medicines, including through results-based contracts...   Read More

Medicare Monday: How Part B has evolved over the years

By Nicole Longo  |    July 24, 2017
With Medicare’s birthday rapidly approaching (July 30!), today we’re highlighting a few of the ways reimbursement for physician-administered medicines under Part B has changed since it was first...   Read More

Putting the cost of medicines in context

By Holly Campbell  |    August 4, 2016
Discussions about costs are important. No patient should have to worry about whether they can afford the care they need. At the same time, it is important to look at costs across the health care...   Read More

New Study Examines Clinical Pathways: An Overview of Current Practices and Potential Implications for Patients, Payers, and Providers

By Kelsey Lang  |    July 28, 2015
As health care payers seek to transition to new, value-based payment models, clinical pathways are one strategy payers and providers are using in their efforts to contain costs and promote...   Read More

New Research Highlights Gaps in Quality Measures for Cancer Patients

By Randy Burkholder  |    June 1, 2015
This weekend marked the start of the annual meeting of The American Society of Clinical Oncology (ASCO).  This year’s meeting, which features a theme of “Innovation and Illumination,” highlights the...   Read More

Working Together to Deliver Hope to Patients

By Robert Zirkelbach  |    January 20, 2015
When President Obama held his end-of-year press conference last month, he struck a clear and upbeat tone: “A new future is ready to be written. We've set the stage for this American moment.  And I'm...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates

Trending Posts

Most Popular Posts

Pharmaceutical Research and Manufacturers of America®
950 F Street, NW Suite 300, Washington, DC 20004

Please be advised that this page contains pixel tags. To learn more about what pixel tags are, why and how
we and third parties use pixel tags, and how that use affects you, visit our privacy policy and review
"1. Information Collection."